Released Aug 11, 2020, after the close
10-Q filed Aug 12, 2020, 43 days after period end · 0001636422-20-000069
Q2 2020 · 10-Q
Revenue$43.26M$43.26M +17.5% vs Q2 2019−4.1% vs Q1 2020
Net Income-$27.18M-$27.18M N/M vs Q2 2019N/M vs Q1 2020
EPS Diluted-$0.71-$0.71 N/M vs Q2 2019N/M vs Q1 2020
Operating Income-$15,640,000N/M
Operating Cash Flowderived-$751,000N/M
Free Cash Flowderived-$1,112,000N/M
Margins · derived
Operating margin-36.2%−10.7 pt vs Q2 2019
Net margin-62.8%−33.8 pt vs Q2 2019
What the release said
The release
Same quarter
| Metric | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|
| Revenue | $43.26M | $36.80M | $22.99M |
| Net Income | -$27.18M | -$10.69M | -$19.32M |
| EPS Diluted | -$0.71 | -$21.98 | -$3.53 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR